Pharma Can Pay for No Play, Supreme Cour

Amplify’d from
Without providing comment, the Supreme Court decided not to review a federal appeals court ruling that allows pharmaceutical companies to pay competitors to
Last year, the a New York-based federal appeals court dismissed a legal challenge to a 1997 deal in which Bayer AG paid Teva Pharmaceutical's Barr Laboratories not to develop a generic version of the antibiotic ciprofloxacin, saying that such an action does not violate antitrust law
he l
The legal challenge was raised by several pharmacy chains, which appealed the ruling to the Supreme Court